The Effects of Nateglinide Following Oral Glucose Load in Impaired Glucose Tolerance Subjects : Rapid Insulin Stimulation by Nateglinide in IGT Subjects
スポンサーリンク
概要
- 論文の詳細を見る
- 2002-12-01
著者
-
Hirose Takahisa
Department Of Internal Medicine Nishinomiya Municipal Central Hospital
-
Mizuno Ryuzo
Department Of Internal Medicine Nishinomiya Municipal Central Hospital
-
YOSHIMOTO TAKAHIKO
Department of Internal Medicine, Nishinomiya Municipal Central Hospital
-
Yoshimoto Takahiko
Department Of Internal Medicine Nishinomiya Municipal Central Hospital
-
Yoshimoto Takahiko
Department Of Algesiology Aichi Medical University
関連論文
- Long-Term Efficacy of Insulin Glargine After Switching from NPH Insulin as Intensive Replacement of Basal Insulin in Japanese Diabetes Mellitus : Comparison of Efficacy between Type 1 and Type 2 diabetes (JUN-LAN Study 1.2)
- Long-term Effect of Combination Therapy with Mitiglinide and Once Daily Insulin Glargine in Patients who were Successfully Switched from Intensive Insulin Therapy in Short-term Study
- Intracellular lipid accumulation and insulin resistance in skeletal muscle and liver
- Therapeutic Efficacy of Mitiglinide Combined with Once Daily Insulin Glargine after Switching from Multiple Daily Insulin Regimen of Aspart Insulin and Glargine in Patients with Type 2 Diabetes Mellitus
- Aldose Reductase Inhibitor, Epalrestat, Reduces Lipid Hydroperoxides in Type 2 Diabetes
- Angiotensin II Type 1 Receptor Blocker Reduces Monocyte Adhesion to Endothelial Cells in Spontaneously Hypertensive Rats
- Association of C-reactive Protein with Early-stage Carotid Atherosclerosis in Japanese Patients with Early-state Type 2 Diabetes Mellitus
- Efficacy and Adverse Effects of Nateglinide in Early Type 2 Diabetes. Comparison with Voglibose in a Cross-over Study
- Strict Glycemic Control Ameliorates the Increase of Carotid IMT in Patients with Type 2 Diabetes
- Characteristics of Japanese Subjects Who Progress from Normal to Impaired Glucose Tolerance. Longitudinal Study Excluding Changes in Body Weight
- Acute Onset and Worsening of Diabetes Concurrent with Administration of Statins
- Dramatic Improvement of Blood Glucose Control after Pioglitazone Treatment in Poorly Controlled Over-weight Diabetic Patients with Myotonic Dystrophy
- Rationale and Design of the Carotid Plaque in Human for All Evaluations With Aggressive Rosuvastatin Therapy (CHALLENGER Trial) : Evaluation by Magnetic Resonance Imaging(Imaging)
- Combined Expression of Transcription Factors Induces AR42J-B13 Cells to Differentiate into Insulin-Producing Cells
- Repetitive Postprandial Hypertriglyceridemia Induces Monocyte Adhesion to Aortic Endothelial Cells in Goto-Kakizaki Rats
- Comparison of Effects of Olmesartan and Telmisartan on Blood Pressure and Metabolic Parameters in Japanese Early-Stage Type-2 Diabetics with Hypertension
- 2-Methoxyestradiol Reduces Monocyte Adhesion to Aortic Endothelial Cells in Ovariectomized Rats
- Calcium Channel Blocker, Azelnidipine, Reduces Lipid Hydroperoxides in Patients with Type 2 Diabetes Independent of Blood Pressure
- Clinical Characteristics Influencing the Effectiveness of Metformin on Japanese Type 2 Diabetes Receiving Sulfonylureas
- TNF-α Inhibits 3T3-L1 Adipocyte Differentiation without Downregulating the Expression of C/EBPβ and δ
- The Effects of Nateglinide Following Oral Glucose Load in Impaired Glucose Tolerance Subjects : Rapid Insulin Stimulation by Nateglinide in IGT Subjects
- Frequency components of systolic blood pressure variability reflect vasomotor and cardiac sympathetic functions in conscious rats
- Investigation of clinical factors associated with development of chronic kidney disease and eGFR decline in Japanese patients with type 2 diabetes mellitus
- Efficacy and adverse effects of low-dose nateglinide in early type 2 diabetes : comparison with acarbose in a crossover study
- Superior thyroid artery mean peak systolic velocity for the diagnosis of thyrotoxicosis in Japanese patients
- Administration of insulin glargine thrice weekly by medical staff at a dialysis unit : a new insulin regimen for diabetic management in physically impaired patients undergoing hemodialysis